Dabigatran Etexilate
NDC 31722-622, Dabigatran Etexilate, capsule, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-622
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207961
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-622 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DABIGATRAN ETEXILATE MESYLATE150 mg/1
Pharmacologic classes
Direct Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-622-32 | 31722062232 | 10 BLISTER PACK in 1 CARTON (31722-622-32) / 6 CAPSULE in 1 BLISTER PACK |
| 31722-622-60 | 31722062260 | 60 CAPSULE in 1 BOTTLE (31722-622-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3c24e235-218b-438e-9456-42c18ff01913NADAC price for package 31722062232
GET /v1/drugs/nadac/31722062232NADAC price for package 31722062260
GET /v1/drugs/nadac/31722062260
Use it
Look up 31722-622 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-622 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-622. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.